Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Clinical trial NCT06588283 · COMPLETED
Trial details
- NCT number
- NCT06588283
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-01-08
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.